Short answer
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) filed its Q3 2026 10-Q quarterly report on Nov 6, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $759M (up 52.9% year over year) with net income of $6M.
Q3 2026 key financials · XBRL
- Revenue
- $759M
- +52.9% YoY · +2.2% QoQ
- Net income
- $6M
- +146.6% YoY · −77.0% QoQ
- Operating margin
- 0.8%
- EPS (diluted)
- $0.01
- −80.0% QoQ
Source: XBRL data from the CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) Q3 2026 10-Q on SEC EDGAR. USD.
CLOVER HEALTH INVESTMENTS, CORP. /DE Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $759.3M, up 52.9% YoY, driven by 46% membership growth and 7% higher per-member premiums
- Net income $6.4M vs $24.4M loss YoY, adjusted EBITDA $16.1M vs $2.1M
- Insurance segment: premiums $748.8M, benefits expense ratio 91.1% vs 93.5% YoY
- Cash, equivalents and investments $512.6M vs $319.9M at December 31, 2025
- Operating cash flow $203.5M vs $1.2M YoY, with $73.1M investment purchases and $5.7M financing outflow
Risk Factors
- No material changes in risk factors from the 2025 Form 10-K
- Carried-forward risk: adverse events could materially harm business, financial condition, and results
- Market risk: risk events could cause Class A common stock price declines, potentially permanent
- Regulatory disclosure risk: future SEC filings may update currently disclosed risk factors
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other CLOVER HEALTH INVESTMENTS, CORP. /DE quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.